The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
October 31st 2024
For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Multimodality breast cancer screening shows possible boon for high-risk women
December 4th 2009Breast cancer detection rates increase substantially when women at high risk and those with dense breasts undergo mammography and ultrasound annually, according to a study presented Wednesday at the 2009 RSNA meeting. MRI is an even more effective technique when used with mammography, but only for women who are at high risk for the condition.
Advanced MRI reveals damage in brains of retired NFL football players
December 3rd 2009The brains of 16 retired National Football League players with known cognitive impairment show signs of damaging atrophy, according to advanced MRI studies described Wednesday at the 2009 RSNA annual meeting.
GE brings its first wide-bore 1.5T MR scanner to RSNA 2009
December 3rd 2009A high-field, wide-bore MR scanner from GE Healthcare is making its first appearance at an RSNA meeting. The system, called Optima MR450w, was officially unveiled some three months ago, but RSNA 2009 is its first major trade show.
Breast MRI assesses tumor size the best prior to surgery, post-treatment
December 2nd 2009MRI is the best method to assess breast cancer tumor size prior to surgery and after chemotherapy, according to findings from the American College of Radiology Imaging Network trial 6657. Size on mammography does not correlate with true residual disease in patients treated with neoadjuvant chemotherapy and thus MRI is the best modality, the researchers said.
Manganese liver contrast medium may help to cut imaging times
December 1st 2009CMC-001, an investigational MRI liver contrast medium, may be at least a partial answer to reducing the long imaging times that have frustrated patients and encouraged radiologists to look for imaging alternatives to aid diagnosis of hepatocellular carcinoma and colon cancer metastases in the liver. A phase III trial indicates it is as sensitive as a gadolinium-enhanced MRI for detecting colon cancer metastases, but at the cost of lower specificity.
Siemens unveils wide-bore MR scanners at RSNA 2009
December 1st 2009Siemens brought two blockbuster MR offerings to the RSNA meeting this week: the 3T Skyra and 1.5T Aera. The two new products, works-in-progress pending FDA clearance but scheduled to begin shipping by mid-2010, promise a productivity lift through their patient-friendly bores, measuring 70 cm wide, and automation that simplifies complex scan tasks.
Siemens IT platform promises boost in MR, CT productivity
December 1st 2009Siemens unveiled a new information technology at RSNA 2009: software that promises to do the tedious and time-consuming tasks involved in reading MR and CT exams. The new product, a work-in-progress pending FDA clearance, is an outgrowth of the syngo platform that Siemens has used for years to provide consistency in data processing among its modalities.
Digital mammo plus breast MRI proves clinically beneficial, but not cost-effective
December 1st 2009Digital mammography plus MRI is the most clinically effective strategy for screening women carrying a genetic mutation known to increase the risk for breast cancer. However, unless the cost of breast MRI decreases substantially, the modality doesn’t translate as cost-effective, according to a study presented on Tuesday at the RSNA 2009 meeting.
3T MRI unveils links between physical exertion, osteoarthritis
December 1st 2009Using 3T MR imaging, California researchers have found that high levels of physical activity may be linked to knee abnormalities in middle-aged men and women. People between the ages of 45 and 55 who engage in several hours of walking, sports, or other types of exercise per week may be at greater risk of developing osteoarthritis than less active adults, according to a study presented Monday at the 2009 RSNA meeting.
Lesion size and patient age predict pathology for breast cancer
November 29th 2009Lesion size, patient age, and current ipsilateral breast cancer are statistically significant predictors of pathologic outcome for nonmasslike enhancement lesions seen on breast MRI, according to a scientific session presented on Sunday at the RSNA 2009 meeting.
Size alone should not determine biopsy decision, RSNA study finds
November 29th 2009Radiologists will often not biopsy small lesions because they assume the lesions are benign. But the decision to do so could mean missing malignant cases, according to a scientific session presented Sunday at the RSNA 2009 meeting.
Abundance of MRI scanners correlates to inappropriate use for low back pain care
November 25th 2009Patients with low back pain who live in areas with many MRI machines are more likely to get scanned and undergo surgery than those in low-availability areas, according to a study looking at Medicare claims data. Patients with low back pain, however, rarely benefit from MRI scans or surgery, so the procedures are often unnecessary.
Expanded MR protocol improves assessment of myocardial infarction
November 6th 2009Combining T2-weighted MRI to detect microvascular obstructions with delayed-enhancement imaging to measure myocardial viability offers clinicians a better way to assess myocardial infarction, according to a new study from Japan.
ACR predicts ‘access catastrophe’ from 16% Medicare rate cuts
November 4th 2009The American College of Radiology is predicting that imaging access will plunge and patient waiting times will soar from new Medicare Physician Fee Schedule rules that will cut Medicare payments for outpatient imaging by an estimated 16% next year.
2010 Medicare fee schedule boosts equipment utilization rate
November 2nd 2009CMS will increase the equipment utilization rate assumption used to determine the practice expense for all nontherapeutic medical equipment, including diagnostic imaging systems, from 50% to 90% under new Medicare fee schedule rules announced Friday. In a bit of good news for radiology, CMS said it remains on track to require that suppliers of advanced imaging services become accredited by 2012.